Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci

被引:55
作者
Dessing, Mark C. [1 ,2 ]
Florquin, Sandrine [3 ]
Paton, James C. [4 ]
van der Poll, Tom [1 ,2 ]
机构
[1] Univ Amsterdam, Ctr Infect & Immun Amsterdam, NL-1012 WX Amsterdam, Netherlands
[2] Univ Amsterdam, Ctr Expt & Mol Med, NL-1012 WX Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Pathol, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands
[4] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia
关键词
D O I
10.1111/j.1462-5822.2007.01035.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Toll-like receptors (TLRs) are pattern recognition receptors that recognize conserved molecular patterns expressed by pathogens. Pneumolysin, an intracellular toxin found in all Streptococcus pneumoniae clinical isolates, is an important virulence factor of the pneumococcus that is recognized by TLR4. Although TLR2 is considered the most important receptor for Gram-positive bacteria, our laboratory previously could not demonstrate a decisive role for TLR2 in host defence against pneumonia caused by a serotype 3 S. pneumoniae-Here we tested the hypothesis that in the absence of TLR2, S. pneumoniae can still be sensed by the immune system through an interaction between pneumolysin and TLR4. C57BL/6 wild-type (WT) and TLR2 knockout (KO) mice were intranasally infected with either WT S. pneumoniae D39 (serotype 2) or the isogenic pneumolysin-deficient S. pneumoniae strain D39 PLN. TLR2 did not contribute to antibacterial defence against WT S. pneumoniae D39. In contrast, pneumolysin-deficient S. pneumoniae only grew in lungs of TLR2 KO mice. TLR2 KO mice displayed a strongly reduced early inflammatory response in their lungs during pneumonia caused by both pneumolysin-producing and pneumolysin-deficient pneumococci. These data suggest that pneumolysin-induced TLR4 signalling can compensate for TLR2 deficiency during respiratory tract infection with S. pneumoniae.
引用
收藏
页码:237 / 246
页数:10
相关论文
共 39 条
[1]   Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice [J].
Albiger, B ;
Sandgren, A ;
Katsuragi, H ;
Meyer-Hoffert, U ;
Beiter, K ;
Wartha, F ;
Hornef, M ;
Normark, S ;
Normark, BH .
CELLULAR MICROBIOLOGY, 2005, 7 (11) :1603-1615
[2]  
Alouf JE, 2000, INT J MED MICROBIOL, V290, P351
[3]   PNEUMOLYSIN-NEGATIVE MUTANT OF STREPTOCOCCUS-PNEUMONIAE CAUSES CHRONIC BACTEREMIA RATHER THAN ACUTE SEPSIS IN MICE [J].
BENTON, KA ;
EVERSON, MP ;
BRILES, DE .
INFECTION AND IMMUNITY, 1995, 63 (02) :448-455
[4]   Treatment of community-acquired pneumonia - IDSA guidelines [J].
Bernstein, JM .
CHEST, 1999, 115 (03) :9S-13S
[5]   Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins [J].
Berry, AM ;
Paton, JC .
INFECTION AND IMMUNITY, 2000, 68 (01) :133-140
[6]   REDUCED VIRULENCE OF A DEFINED PNEUMOLYSIN-NEGATIVE MUTANT OF STREPTOCOCCUS-PNEUMONIAE [J].
BERRY, AM ;
YOTHER, J ;
BRILES, DE ;
HANSMAN, D ;
PATON, JC .
INFECTION AND IMMUNITY, 1989, 57 (07) :2037-2042
[7]   Role of toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice [J].
Branger, J ;
Knapp, S ;
Weijer, S ;
Leemans, JC ;
Pater, JM ;
Speelman, P ;
Florquin, SR ;
van der Poll, T .
INFECTION AND IMMUNITY, 2004, 72 (02) :788-794
[8]   Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia [J].
Campbell, GD .
CHEST, 1999, 115 (03) :14S-18S
[9]   THE ROLE OF PNEUMOLYSIN AND AUTOLYSIN IN THE PATHOLOGY OF PNEUMONIA AND SEPTICEMIA IN MICE INFECTED WITH A TYPE-2 PNEUMOCOCCUS [J].
CANVIN, JR ;
MARVIN, AP ;
SIVAKUMARAN, M ;
PATON, JC ;
BOULNOIS, GJ ;
ANDREW, PW ;
MITCHELL, TJ .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (01) :119-123
[10]   Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro [J].
Cockeran, R ;
Durandt, C ;
Feldman, C ;
Mitchell, TJ ;
Anderson, R .
JOURNAL OF INFECTIOUS DISEASES, 2002, 186 (04) :562-565